IDiyas

For the Inventor, By the Inventor

Raritan, NJ, United States of America

Peter A Nemoto

USPTO Granted Patents = 51


Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 94(Granted Patents)

Forward Citations (Not Self Cited) = 92(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Bound Brook, NJ (US) (1992)
  • Piscataway, NJ (US) (1992 - 1997)
  • Evanston, IL (US) (2001)
  • Raritan, NJ (US) (1993 - 2002)

Company Filing History:

goldMedal27 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal19 out of 236 
 
Hoechst Marion Roussel
 patents
bronzeMedal4 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 1 out of 832,680 
Other
 patents

Years Active: 1992-2002

Loading Chart...
Loading Chart...
51 patents (USPTO):Explore Patents
1. 6420390 - Heteroarylpiperidines and their use as antipsychotics (2002-07-16),
2. 6251907 - 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics (2001-06-26),
3. 6207680 - Heteroarylpiperidines and their use as antipsychotics and analgesics (2001-03-27),
4. RE37029 - N-[(3-heteroaryl-1-pyrrolidinyl)-alkyl]phthalimides and related compounds and their therapeutic utility (2001-01-23),
5. 6043240 - 3-heteroaryl-1-pyrrolidinealkylamines and derivatives thereof and their (2000-03-28),
6. 6008348 - Antipsychotic agents, compositions and method of use (1999-12-28),
7. 5998417 - N-[(4-heteroaryl-1-piperazinyl) alkyl]phthalimides and related compounds (1999-12-07),
8. 5977140 - N-[(4-Heteroaryl-1-Piperidinyl)Alkly] Phthalimides and related compounds (1999-11-02),
9. 5977113 - 4-heteroaryl-1-piperazine alkylamines and their therapeutic utility (1999-11-02),
10. 5965554 - Antipsychotic agents, compositions and method of use (1999-10-12),
11. 5965546 - 1-[(2-pyrimidinyloxy)alkyl]4-(heteroaryl)piperazines and related (1999-10-12),
12. 5919798 - 4-heteroaryl-1-piperidinealkanols and derivatives thereof and their (1999-07-06),
13. 5889004 - 4-heteroaryl-1-piperazinealkylthiols and derivatives thereof and their (1999-03-30),
14. 5874435 - 4-heteroaryl-1-piperazinealkanols and derivatives thereof and their (1999-02-23),
15. 5854243 - 3-heteroaryl-1-pyrrolidinealkylthiols and derivatives thereof and their (1998-12-29),

Title: Peter A. Nemoto: Pioneer in Antipsychotic and Analgesic Innovations

Introduction

Peter A. Nemoto, based in Raritan, NJ, is a distinguished inventor, holding an impressive total of 51 patents. His innovative work primarily revolves around the development of novel compounds used in the treatment of psychoses and as analgesics, contributing significantly to the fields of pharmacology and medicine.

Latest Patents

Among his notable contributions, Peter A. Nemoto's latest patents include key advancements in the formulation of heteroarylpiperidines and their application as antipsychotic and analgesic agents. These compounds, specifically heteroarylpiperidines, pyrrolidines, and piperazines, have demonstrated effectiveness in treating psychoses by administering a psychoses-treating effective amount to mammals. The depot derivatives of these compounds offer long-acting effects, enhancing their therapeutic utility. Additionally, his work on 1-(aryloxyalkyl)-4-(heteroaryl)piperazines and related compounds further emphasizes their role as beneficial agents in managing both psychotic disorders and pain relief.

Career Highlights

Peter A. Nemoto has made significant strides in his career, working with notable companies such as Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. His contributions in these organizations have paved the way for innovative treatments that address critical mental health issues, showcasing his commitment to advancing pharmaceutical science.

Collaborations

Throughout his career, Peter Nemoto has collaborated with esteemed professionals in the field, including Joseph T. Strupczewski and Edward J. Glamkowski. These collaborative efforts have fostered an environment of innovation, leading to the successful development of therapeutic compounds that have the potential to transform patient care.

Conclusion

Peter A. Nemoto's impressive portfolio of 51 patents underscores his role as a pioneer in the development of antipsychotic and analgesic innovations. His dedicated work has not only advanced pharmaceutical research but also provided new hope for individuals dealing with psychotic disorders and pain management. The legacy of his contributions continues to inspire future generations of inventors and researchers in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…